Clinical trial
Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus
NCT00689377 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- July 31, 2008
- Enrollment
- 9,000 (actual)
- Sites
- 331
Conditions
As the registry lists them; a condition with its own page is linked.
moderate risk for cardiovascular disease (cvd), peripheral arterial disease (pad)